Back to results
US 2012/0232092 A1Published application
Heterocyclic sulfonamides
AssigneeCytokinetics, Inc.
InventorsBradley Paul Morgan, Fady Malik, Erica Anne Kraynack, Alexander Ramon Muci, Xiangping Qian, David J. Morgans, JR.
Life of this patent
Estimating the term…
Abstract
Certain substituted sulfonamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Claims13
1-14. (canceled)
A compound of the following formula:
- wherein:
- R1, R2 and the nitrogen to which they are attached form a morphlin-4-yl ring optionally substituted with one, two, or three groups selected from alkyl, halogen, hydroxy, alkoxy, alkylenedioxy, carboxy, acyloxy, alkoxycarbonyl, alkoxycarbonylamino, alkylcarbonylamino, aminocarbonyl, aminocarbonylamino, cyano, acyl, oxo, nitro, amino, sulfanyl, sulfinyl, sulfonyl, aminosulfonyl, amidino, phenyl, benzyl, heteroaryl, heterocyclyl, aryloxy, aralkoxy, heteroaryloxy, and heteroaralkoxy, wherein the amino(s) in the aminocarbonyl, amino, or aminosulfonyl is optionally substituted with alkyl;
- R3 is an aryl or heteroaryl group, which is optionally substituted with a halogen, lower alkoxy, aryl or heteroaryl group;
- R4 is halogen;
- R5 is hydrogen, halogen, hydroxy, or lower alkyl;
- R6 and R7 are independently selected from hydrogen, halogen, hydroxy, and lower alkyl;
- or a pharmaceutically acceptable salt thereof.
4 more elements
Dependencies are inferred from the claim text.